University of California Los Angeles campus

Los Angeles, California 90095

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Immunology / Infectious Diseases, Other Clinical Trial
Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California Los Angeles campus
mi
from
Los Angeles, CA
Click here to add this to my saved trials